We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Lakeland Financial Corp
LKFN
$1.55B
| $309K | ﹤0.01% |
5,030
| – | – |
|
|
RC
1377
Ready Capital
RC
$294M
| $309K | ﹤0.01% |
37,830
+12,700
| +51% | +$108K |
|
1378
Ichor Holdings
ICHR
$2.71B
| $308K | ﹤0.01% |
8,000
| – | – |
|
|
LADR
1379
Ladder Capital
LADR
$1.27B
| $308K | ﹤0.01% |
27,300
| – | – |
|
|
ARI
1380
Apollo Commercial Real Estate
ARI
$886M
| $306K | ﹤0.01% |
31,302
+6,200
| +25% | +$63.9K |
|
1381
Aurinia Pharmaceuticals
AUPH
$2B
| $306K | ﹤0.01% |
53,600
+20,100
| +60% | +$106K |
|
1382
Vertex
VERX
$2.02B
| $306K | ﹤0.01% |
8,500
+1,800
| +27% | +$57.9K |
|
1383
RLJ Lodging Trust
RLJ
$1.67B
| $304K | ﹤0.01% |
31,541
| – | – |
|
|
AGNT
1384
AGNT Inc
AGNT
$722M
| $302K | ﹤0.01% |
26,800
+9,100
| +51% | +$99.6K |
|
|
OPRA
1385
Opera Ltd
OPRA
$1.78B
| $299K | ﹤0.01% |
21,300
-6,000
| -22% | -$85.2K |
|
1386
StoneCo
STNE
$2.49B
| $299K | ﹤0.01% |
24,947
| – | – |
|
1387
Knowles
KN
$3.29B
| $297K | ﹤0.01% |
17,190
+3,600
| +26% | +$60.4K |
|
1388
Greif
GEF
$5.06B
| $296K | ﹤0.01% |
5,151
| – | – |
|
1389
Harmony Biosciences
HRMY
$2.25B
| $296K | ﹤0.01% |
9,800
+1,700
| +21% | +$51.1K |
|
1390
OFG Bancorp
OFG
$2.26B
| $296K | ﹤0.01% |
7,900
+1,700
| +27% | +$61.9K |
|
1391
Omnicell
OMCL
$1.7B
| $296K | ﹤0.01% |
+10,923
| New | +$316K |
|
1392
Astrana Health
ASTH
$1.83B
| $296K | ﹤0.01% |
7,300
+100
| +1% | +$3.97K |
|
1393
JetBlue
JBLU
$2.22B
| $295K | ﹤0.01% |
48,400
| – | – |
|
1394
Sylvamo
SLVM
$1.53B
| $295K | ﹤0.01% |
4,300
-3,000
| -41% | -$198K |
|
1395
Arcus Biosciences
RCUS
$3.68B
| $294K | ﹤0.01% |
19,300
+6,500
| +51% | +$105K |
|
1396
Navient
NAVI
$867M
| $293K | ﹤0.01% |
20,100
| – | – |
|
1397
Constellium
CSTM
$3.99B
| $292K | ﹤0.01% |
15,500
-2,500
| -14% | -$52K |
|
|
KW
1398
DELISTED
Kennedy-Wilson Holdings
KW
| $292K | ﹤0.01% |
30,076
+3,500
| +13% | +$32.7K |
|
1399
Stewart Information Services
STC
$2.04B
| $292K | ﹤0.01% |
4,700
| – | – |
|
|
DEA
1400
Easterly Government Properties
DEA
$1.18B
| $291K | ﹤0.01% |
9,400
+1,160
| +14% | +$34.3K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.